Silver Book Fact

Annual flu vaccine could save 275,000 QALYs

Offering the influenza vaccine annually to all people over the age of 50 would save around 275,000 quality-adjusted life years over the lifetimes of a birth cohort of 4 million.

Macioesk, Michael V., Leif I. Solberg, Ashley B. Coffield, Nichol M. Edwards, and Michael J. Goodman. Infuenza Vaccination: Health Impact and Cost Effectiveness Among Adults Aged 50 to 64 and 65 and Older. Am J Prev Med. 2006; 31(1): 72-9. http://www.ajpmonline.org/article/S0749-3797(06)00120-6/fulltext

Reference

Title
Infuenza Vaccination: Health Impact and Cost Effectiveness Among Adults Aged 50 to 64 and 65 and Older
Publication
Am J Prev Med
Publication Date
2006
Authors
Macioesk, Michael V., Leif I. Solberg, Ashley B. Coffield, Nichol M. Edwards, and Michael J. Goodman
Volume & Issue
Volume 31, Issue 1
Pages
72-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Future Value

Related Facts

  • Flu vaccine use can reduce illness risk in U.S. by 60%
    Recent studies from the Centers for Disease Control and Prevention show that the influenza vaccine can reduce the risk of illness in the overall U.S. population by around 60%. …  
  • Flu vaccine use reduces disease burden
    Use of the LAIV (live attenuated influenza virus) in healthy adults ages 18 to 64 reduced febrile illness by 19% and upper respiratory tract illnesses by 24%. It also…  
  • Significant savings from zoster vaccine
    In a cost-effectiveness analysis, investigators estimated the zoster vaccine cost $44,000 per quality-adjusted life year saved for a 70-year-old woman.  
  • Use of shingles vaccines significantly reduced disease burden
    Use of a live attenuated VZV (varicella-zoster vaccine) in a randomized trial reduced the burden of illness from shingles by 61.1% and the incidence of postherpetic neuralgia (PHN) by 66.5%.  
  • Effectiveness of pneumonia vaccine
    PPSV23 (pneumococcal polysaccharide vaccine) protects against 23 types of pneumococcal bacteria and is 60% to 80% effective in preventing pneumococcal bacteremia in adults over the age of 65 who are…